{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T23:14:05Z","timestamp":1792019645035,"version":"4.4.0"},"reference-count":61,"publisher":"MDPI AG","issue":"5","license":[{"start":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T00:00:00Z","timestamp":1772496000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"MCA Partners Advisory Board grant"},{"name":"National Cancer Institute Cancer Center Support Grant","award":["P30 CA168524"],"award-info":[{"award-number":["P30 CA168524"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancers"],"abstract":"<jats:p>Background\/Objectives: Molecular subtyping of pediatric B-cell acute lymphoblastic leukemia (B-ALL) has improved patient outcomes through stratification and selection of targeted therapies. Despite extensive genomic and transcriptomic profiling of this cancer, few studies to date have characterized the proteomic landscape, although proteins are the direct targets of many therapeutic agents. Methods: In this study, we demonstrate the utility of multi-omic integration of global transcriptomic, proteomic, and phosphoproteomic profiles of samples from patients diagnosed with either of two B-ALL subtypes\u2014Ph-like (BCR::ABL1-like) and ETV6::RUNX1. Through individual and multi-omic analysis, we recapitulate known transcriptomic findings and identify novel subtype-specific proteomic and phosphoproteomic biomarkers. Conclusions: Our findings suggest a previously undescribed role for calcium-dependent signaling processes in Ph-like B-ALL, which has the potential to serve as a novel avenue for targeted treatments. By integrating multiple -omics modalities, we identify not only features of interest but also begin to unravel the regulatory interactions driving subtype-specific mechanisms of leukemogenesis. This integrated analytic approach paves the way for enhanced precision medicine for precise subtyping and treatment selection for pediatric leukemia patients.<\/jats:p>","DOI":"10.3390\/cancers18050813","type":"journal-article","created":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T16:18:45Z","timestamp":1772554725000},"page":"813","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Integrated Multi-Omic Analysis Reveals Novel Subtype-Specific Regulatory Interactions in Pediatric B-Cell Acute Lymphoblastic Leukemia"],"prefix":"10.3390","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0862-1923","authenticated-orcid":false,"given":"Irina","family":"Pushel","sequence":"first","affiliation":[{"name":"Genomic Medicine Center, Children\u2019s Mercy Kansas City, Kansas City, MO 64108, USA"},{"name":"School of Medicine, University of Missouri-Kansas City, Kansas City, MO 64110, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-6542-8785","authenticated-orcid":false,"given":"Zachary S.","family":"Clark","sequence":"additional","affiliation":[{"name":"Department of Cancer Biology, University of Kansas Medical Center, Kansas City, KS 66160, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa A.","family":"Lansdon","sequence":"additional","affiliation":[{"name":"School of Medicine, University of Missouri-Kansas City, Kansas City, MO 64110, USA"},{"name":"Pathology and Laboratory Medicine, Children\u2019s Mercy Kansas City, Kansas City, MO 64108, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7912-1862","authenticated-orcid":false,"given":"Byunggil","family":"Yoo","sequence":"additional","affiliation":[{"name":"Genomic Medicine Center, Children\u2019s Mercy Kansas City, Kansas City, MO 64108, USA"},{"name":"Pathology and Laboratory Medicine, Children\u2019s Mercy Kansas City, Kansas City, MO 64108, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3132-6380","authenticated-orcid":false,"given":"Michaella J.","family":"Rekowski","sequence":"additional","affiliation":[{"name":"Department of Cancer Biology, University of Kansas Medical Center, Kansas City, KS 66160, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7906-5151","authenticated-orcid":false,"given":"Nicole M.","family":"Wood","sequence":"additional","affiliation":[{"name":"School of Medicine, University of Missouri-Kansas City, Kansas City, MO 64110, USA"},{"name":"Division of Hematology\/Oncology\/Bone Marrow Transplant, Children\u2019s Mercy Kansas City, Kansas City, MO 64108, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7568-2585","authenticated-orcid":false,"given":"Michael P.","family":"Washburn","sequence":"additional","affiliation":[{"name":"Department of Cancer Biology, University of Kansas Medical Center, Kansas City, KS 66160, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5238-1349","authenticated-orcid":false,"given":"Midhat S.","family":"Farooqi","sequence":"additional","affiliation":[{"name":"Genomic Medicine Center, Children\u2019s Mercy Kansas City, Kansas City, MO 64108, USA"},{"name":"School of Medicine, University of Missouri-Kansas City, Kansas City, MO 64110, USA"},{"name":"Pathology and Laboratory Medicine, Children\u2019s Mercy Kansas City, Kansas City, MO 64108, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,3,3]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1007\/s11684-020-0821-6","article-title":"Emerging Molecular Subtypes and Therapeutic Targets in B-Cell Precursor Acute Lymphoblastic Leukemia","volume":"15","author":"Li","year":"2021","journal-title":"Front. Med."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"3577","DOI":"10.1002\/cncr.29573","article-title":"Childhood Acute Lymphoblastic Leukemia: Integrating Genomics into Therapy","volume":"121","author":"Tasian","year":"2015","journal-title":"Cancer"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.jmoldx.2023.09.013","article-title":"Transcriptome Sequencing Allows Comprehensive Genomic Characterization of Pediatric B-Cell Acute Lymphoblastic Leukemia in an Academic Clinical Laboratory","volume":"26","author":"Hu","year":"2023","journal-title":"J. Mol. Diagn."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"e1913968","DOI":"10.1001\/jamanetworkopen.2019.13968","article-title":"Comparative Tumor RNA Sequencing Analysis for Difficult-to-Treat Pediatric and Young Adult Patients With Cancer","volume":"2","author":"Vaske","year":"2019","journal-title":"JAMA Netw. Open"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1038\/s41375-018-0032-1","article-title":"Proteomic and Genomic Integration Identifies Kinase and Differentiation Determinants of Kinase Inhibitor Sensitivity in Leukemia Cells","volume":"32","author":"Casado","year":"2018","journal-title":"Leukemia"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1038\/s41392-022-01288-1","article-title":"Integrative Phosphoproteomics Defines Two Biologically Distinct Groups of KMT2A Rearranged Acute Myeloid Leukaemia with Different Drug Response Phenotypes","volume":"8","author":"Casado","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Nguyen, N.H.K., Wu, H., Tan, H., Peng, J., Rubnitz, J.E., Cao, X., Pounds, S., and Lamba, J.K. (2021). Global Proteomic Profiling of Pediatric AML: A Pilot Study. Cancers, 13.","DOI":"10.3390\/cancers13133161"},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Veltri, G., Lovisa, F., Cortese, G., Pillon, M., Carraro, E., Cesaro, S., Provenzi, M., Buffardi, S., Francescato, S., and Biffi, A. (2022). Phosphoproteomic Analysis Reveals a Different Proteomic Profile in Pediatric Patients With T-Cell Lymphoblastic Lymphoma or T-Cell Acute Lymphoblastic Leukemia. Front. Oncol., 12.","DOI":"10.3389\/fonc.2022.913487"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.ccell.2022.02.006","article-title":"The Proteogenomic Subtypes of Acute Myeloid Leukemia","volume":"40","author":"Jayavelu","year":"2022","journal-title":"Cancer Cell"},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Kourti, M., Aivaliotis, M., and Hatzipantelis, E. (2023). Proteomics in Childhood Acute Lymphoblastic Leukemia: Challenges and Opportunities. Diagnostics, 13.","DOI":"10.3390\/diagnostics13172748"},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Bernt, K.M., and Hunger, S.P. (2014). Current Concepts in Pediatric Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia. Front. Oncol., 4.","DOI":"10.3389\/fonc.2014.00054"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"e26539","DOI":"10.1002\/pbc.26539","article-title":"Molecular Characterization of Acute Lymphoblastic Leukemia with High CRLF2 Gene Expression in Childhood","volume":"64","author":"Fedders","year":"2017","journal-title":"Pediatr. Blood Cancer"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.ccr.2012.06.005","article-title":"Genetic Alterations Activating Kinase and Cytokine Receptor Signaling in High-Risk Acute Lymphoblastic Leukemia","volume":"22","author":"Roberts","year":"2012","journal-title":"Cancer Cell"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1038\/ng.469","article-title":"Rearrangement of CRLF2 in B-Progenitor\u2013and Down Syndrome\u2013Associated Acute Lymphoblastic Leukemia","volume":"41","author":"Mullighan","year":"2009","journal-title":"Nat. Genet."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"5312","DOI":"10.1182\/blood-2009-09-245944","article-title":"Rearrangement of CRLF2 Is Associated with Mutation of JAK Kinases, Alteration of IKZF1, Hispanic\/Latino Ethnicity, and a Poor Outcome in Pediatric B-Progenitor Acute Lymphoblastic Leukemia","volume":"115","author":"Harvey","year":"2010","journal-title":"Blood"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1056\/NEJMoa1403088","article-title":"Targetable Kinase-Activating Lesions in Ph-like Acute Lymphoblastic Leukemia","volume":"371","author":"Roberts","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"3352","DOI":"10.1182\/blood-2016-12-758979","article-title":"Targetable Kinase Gene Fusions in High-Risk B-ALL: A Study from the Children\u2019s Oncology Group","volume":"129","author":"Reshmi","year":"2017","journal-title":"Blood"},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Kaczmarska, A., \u015aliwa, P., Zawitkowska, J., and Lejman, M. (2021). Genomic Analyses of Pediatric Acute Lymphoblastic Leukemia Ph+ and Ph-Like\u2014Recent Progress in Treatment. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22126411"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1038\/s41375-024-02287-7","article-title":"ETV6::RUNX1 Acute Lymphoblastic Leukemia: How Much Therapy Is Needed for Cure?","volume":"38","author":"Fiocco","year":"2024","journal-title":"Leukemia"},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Rodr\u00edguez-Hern\u00e1ndez, G., Casado-Garc\u00eda, A., Isidro-Hern\u00e1ndez, M., Picard, D., Raboso-Gallego, J., Alem\u00e1n-Arteaga, S., Orfao, A., Blanco, O., Riesco, S., and Prieto-Matos, P. (2021). The Second Oncogenic Hit Determines the Cell Fate of ETV6-RUNX1 Positive Leukemia. Front. Cell Dev. Biol., 9.","DOI":"10.3389\/fcell.2021.704591"},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Kaczmarska, A., Derebas, J., Pinkosz, M., Nied\u017awiecki, M., and Lejman, M. (2023). The Landscape of Secondary Genetic Rearrangements in Pediatric Patients with B-Cell Acute Lymphoblastic Leukemia with t(12;21). Cells, 12.","DOI":"10.3390\/cells12030357"},{"key":"ref_22","unstructured":"Choi, J., Snovida, S.I., Bomgarden, R., and Rogers, J.C. (2017). Sequential Enrichment from Metal Oxide Affinity Chromatography (SMOAC), a Phosphoproteomics Strategy for the Separation of Multiply Phosphorylated from Monophosphorylated Peptides, Thermo Fisher Scientific."},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Orsburn, B.C. (2021). Proteome Discoverer\u2014A Community Enhanced Data Processing Suite for Protein Informatics. Proteomes, 9.","DOI":"10.3390\/proteomes9010015"},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Ahlmann-Eltze, C., and Anders, S. (2020). ProDA: Probabilistic Dropout Analysis for Identifying Differentially Abundant Proteins in Label-Free Mass Spectrometry. bioRxiv, 661496.","DOI":"10.21203\/rs.3.rs-36351\/v1"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"W207","DOI":"10.1093\/nar\/gkad347","article-title":"G:Profiler\u2014Interoperable Web Service for Functional Enrichment Analysis and Gene Identifier Mapping (2023 Update)","volume":"51","author":"Kolberg","year":"2023","journal-title":"Nucleic Acids Res."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"2938","DOI":"10.1093\/bioinformatics\/btx364","article-title":"UpSetR: An R Package for the Visualization of Intersecting Sets and Their Properties","volume":"33","author":"Conway","year":"2017","journal-title":"Bioinformatics"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"3489","DOI":"10.1093\/bioinformatics\/btx415","article-title":"The KSEA App: A Web-Based Tool for Kinase Activity Inference from Quantitative Phosphoproteomics","volume":"33","author":"Wiredja","year":"2017","journal-title":"Bioinformatics"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1038\/nbt.3519","article-title":"Near-Optimal Probabilistic RNA-Seq Quantification","volume":"34","author":"Bray","year":"2016","journal-title":"Nat. Biotechnol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","article-title":"Moderated Estimation of Fold Change and Dispersion for RNA-Seq Data with DESeq2","volume":"15","author":"Love","year":"2014","journal-title":"Genome Biol."},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Meng, C., Kuster, B., Culhane, A.C., and Gholami, A.M. (2014). A Multivariate Approach to the Integration of Multi-Omics Datasets. BMC Bioinform., 15.","DOI":"10.1186\/1471-2105-15-162"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1038\/s41467-019-09234-6","article-title":"Metascape Provides a Biologist-Oriented Resource for the Analysis of Systems-Level Datasets","volume":"10","author":"Zhou","year":"2019","journal-title":"Nat. Commun."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"2498","DOI":"10.1101\/gr.1239303","article-title":"Cytoscape: A Software Environment for Integrated Models of Biomolecular Interaction Networks","volume":"13","author":"Shannon","year":"2003","journal-title":"Genome Res."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1080\/10428190802007726","article-title":"Protein Kinase C Signalling in Leukemia","volume":"49","author":"Redig","year":"2008","journal-title":"Leuk. Lymphoma"},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Immanuel, T., Li, J., Green, T.N., Bogdanova, A., and Kalev-Zylinska, M.L. (2022). Deregulated Calcium Signaling in Blood Cancer: Underlying Mechanisms and Therapeutic Potential. Front. Oncol., 12.","DOI":"10.3389\/fonc.2022.1010506"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1038\/s41467-018-07846-y","article-title":"The Signaling Axis Atypical Protein Kinase C \u03bb\/\u03b9-Satb2 Mediates Leukemic Transformation of B-Cell Progenitors","volume":"10","author":"Nayak","year":"2019","journal-title":"Nat. Commun."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1186\/s43556-025-00340-0","article-title":"Multi-Omics Strategies for Biomarker Discovery and Application in Personalized Oncology","volume":"6","author":"Jiang","year":"2025","journal-title":"Mol. Biomed."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"e8124","DOI":"10.15252\/msb.20178124","article-title":"Multi-Omics Factor Analysis\u2014A Framework for Unsupervised Integration of Multi-omics Data Sets","volume":"14","author":"Argelaguet","year":"2018","journal-title":"Mol. Syst. Biol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1038\/s41467-025-56229-7","article-title":"Molecular and Pharmacological Heterogeneity of ETV6::RUNX1 Acute Lymphoblastic Leukemia","volume":"16","author":"Li","year":"2025","journal-title":"Nat. Commun."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1182\/blood-2016-04-709519","article-title":"Ibrutinib Inhibits CD20 Upregulation on CLL B Cells Mediated by the CXCR4\/SDF-1 Axis","volume":"128","author":"Pavlasova","year":"2016","journal-title":"Blood"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/j.neo.2018.04.004","article-title":"Phenotyping and Target Expression Profiling of CD34+\/CD38\u2212 and CD34+\/CD38+ Stem- and Progenitor Cells in Acute Lymphoblastic Leukemia","volume":"20","author":"Blatt","year":"2018","journal-title":"Neoplasia"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"10534","DOI":"10.1093\/nar\/gkx711","article-title":"CHD3 and CHD4 Form Distinct NuRD Complexes with Different yet Overlapping Functionality","volume":"45","author":"Hoffmeister","year":"2017","journal-title":"Nucleic Acids Res."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"5433","DOI":"10.1038\/sj.onc.1210611","article-title":"The Human Mi-2\/NuRD Complex and Gene Regulation","volume":"26","author":"Denslow","year":"2007","journal-title":"Oncogene"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1002\/j.1460-2075.1993.tb05797.x","article-title":"An Actin-Binding Function Contributes to Transformation by the Bcr-Abl Oncoprotein of Philadelphia Chromosome-Positive Human Leukemias","volume":"12","author":"McWhirter","year":"1993","journal-title":"EMBO J."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"3334","DOI":"10.1182\/blood-2007-01-068122","article-title":"Ph+\/VE-Cadherin+ Identifies a Stem Cell\u2013like Population of Acute Lymphoblastic Leukemia Sustained by Bone Marrow Niche Cells","volume":"110","author":"Wang","year":"2007","journal-title":"Blood"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1016\/j.cellsig.2009.12.012","article-title":"The Bcr\u2013Abl Kinase Regulates the Actin Cytoskeleton via a GADS\/Slp-76\/Nck1 Adaptor Protein Pathway","volume":"22","author":"Preisinger","year":"2010","journal-title":"Cell. Signal."},{"key":"ref_46","doi-asserted-by":"crossref","unstructured":"Vllahu, M., Savarese, M., Cantiello, I., Munno, C., Sarcina, R., Stellato, P., Leone, O., and Alfieri, M. (2025). Application of Omics Analyses in Pediatric B-Cell Acute Lymphoblastic Leukemia. Biomedicines, 13.","DOI":"10.3390\/biomedicines13020424"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1111\/jcmm.12319","article-title":"Proteomics-Based Discovery of Biomarkers for Paediatric Acute Lymphoblastic Leukaemia: Challenges and Opportunities","volume":"18","author":"Wu","year":"2014","journal-title":"J. Cell. Mol. Med."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1182\/blood.V122.21.826.826","article-title":"Development and Validation Of a Highly Sensitive and Specific Gene Expression Classifier To Prospectively Screen and Identify B-Precursor Acute Lymphoblastic Leukemia (ALL) Patients With a Philadelphia Chromosome-Like (\u201cPh-like\u201d or \u201cBCR-ABL1-Like\u201d) Signature For Therapeutic Targeting and Clinical Intervention","volume":"122","author":"Harvey","year":"2013","journal-title":"Blood"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jprot.2016.08.014","article-title":"Label-Free Quantitative Proteomics Reveals Differentially Expressed Proteins in High Risk Childhood Acute Lymphoblastic Leukemia","volume":"150","author":"Xu","year":"2017","journal-title":"J. Proteom."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/1756-8722-6-52","article-title":"Protein Biomarkers Distinguish between High- and Low-Risk Pediatric Acute Lymphoblastic Leukemia in a Tissue Specific Manner","volume":"6","author":"Braoudaki","year":"2013","journal-title":"J. Hematol. Oncol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1002\/cncr.34665","article-title":"Genomic and Proteomic Characterization of Philadelphia-like B-Lineage Acute Lymphoblastic Leukemia: A Report of Indian Patients","volume":"129","author":"Gupta","year":"2023","journal-title":"Cancer"},{"key":"ref_52","doi-asserted-by":"crossref","unstructured":"Ahmed, A.A., Vundamati, D.S., Farooqi, M.S., and Guest, E. (2018). Precision Medicine in Pediatric Cancer: Current Applications and Future Prospects. High. Throughput., 7.","DOI":"10.3390\/ht7040039"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.exphem.2019.05.003","article-title":"Pediatric Leukemia: Moving toward More Accurate Models","volume":"74","author":"Milan","year":"2019","journal-title":"Exp. Hematol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s40164-026-00751-x","article-title":"Single-Cell Profiling Reveals Reprogrammed Hierarchy and Disrupted Immune-Stromal Ecosystem in TP53-Mutated AML","volume":"15","author":"Qiu","year":"2026","journal-title":"Exp. Hematol. Oncol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"4114","DOI":"10.1038\/s41467-025-59362-5","article-title":"Identification of Leukemia-Enriched Signature through the Development of a Comprehensive Pediatric Single-Cell Atlas","volume":"16","author":"Mumme","year":"2025","journal-title":"Nat. Commun."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"2373","DOI":"10.1182\/bloodadvances.2021006076","article-title":"SFPQ-ABL1 and BCR-ABL1 Use Different Signaling Networks to Drive B-Cell Acute Lymphoblastic Leukemia","volume":"6","author":"Brown","year":"2022","journal-title":"Blood Adv."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"16286","DOI":"10.1074\/jbc.M110.108167","article-title":"Phosphorylation-Induced Conformational Changes in the Retinoblastoma Protein Inhibit E2F Transactivation Domain Binding","volume":"285","author":"Burke","year":"2010","journal-title":"J. Biol. Chem."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1007\/s00018-024-05144-z","article-title":"BCLAF1 Binds SPOP to Stabilize PD-L1 and Promotes the Development and Immune Escape of Hepatocellular Carcinoma","volume":"81","author":"Yu","year":"2024","journal-title":"Cell. Mol. Life Sci."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1080\/15384047.2018.1472188","article-title":"Effect of BCLAF1 on HDAC Inhibitor LMK-235-Mediated Apoptosis of Diffuse Large B Cell Lymphoma Cells and Its Mechanism","volume":"19","author":"Li","year":"2018","journal-title":"Cancer Biol. Ther."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"108610","DOI":"10.1016\/j.pharmthera.2024.108610","article-title":"The Therapeutic Potential of Targeting the CHD Protein Family in Cancer","volume":"256","author":"Zhang","year":"2024","journal-title":"Pharmacol. Ther."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1038\/s41467-023-36150-7","article-title":"Chromatin Complex Dependencies Reveal Targeting Opportunities in Leukemia","volume":"14","author":"Najm","year":"2023","journal-title":"Nat. Commun."}],"container-title":["Cancers"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6694\/18\/5\/813\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T05:21:25Z","timestamp":1772688085000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6694\/18\/5\/813"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,3]]},"references-count":61,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2026,3]]}},"alternative-id":["cancers18050813"],"URL":"https:\/\/doi.org\/10.3390\/cancers18050813","relation":{},"ISSN":["2072-6694"],"issn-type":[{"value":"2072-6694","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,3]]}}}